Outcomes Following Intolerance to Tacrolimus/Sirolimus for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant

被引：0
|
作者：
Mirza, Sayeef [1 ]
Tandon, Ankita [1 ]
Jenneman, Dakota [1 ]
Cao, Shu [1 ]
Kumar, Ambuj [2 ]
Kidd, Michelle R. [3 ]
Khimani, Farhad [4 ]
Mishra, Asmita [4 ]
Liu, Hien D. [5 ]
Nishihori, Taiga [6 ]
Perez, Lia [4 ]
Bejanyan, Nelli [4 ,6 ]
Pidala, Joseph [4 ]
Nieder, Michael [4 ]
Elmariah, Hany [4 ]
机构：
[1] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA
[2] Univ S Florida, Program Comparat Effectiveness Res, Morsani Coll Med, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5673
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience
    Hashmi, Hamza
    Bhandari, Shruti
    Dhanoa, Jugraj
    Wu, Xiaoyong
    Rai, Shesh
    Figg, Lindsay
    Baize, Timothy
    Krem, Maxwell
    Hegazi, Mohamed
    Emmons, Robert
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [22] Drug Metabolism Gene Polymorphisms Influence Tacrolimus/Sirolimus Blood Levels and Incidence of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
    Khaled, Samer K.
    Palmer, Joycelynne
    Herzog, Josef
    Stiller, Tracey
    Tsai, Ni-Chun
    Senitzer, David
    Liu, Xueli
    Thomas, Sandra H.
    Shayani, Sepideh
    Weitzel, Jeffrey
    Forman, Stephen J.
    Nakamura, Ryotaro
    BLOOD, 2014, 124 (21)
  • [23] The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease
    Staffas, Anna
    da Silva, Marina Burgos
    van den Brink, Marcel R. M.
    BLOOD, 2017, 129 (08) : 927 - 933
  • [24] A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Cheung, YK
    Van De Ven, C
    del Toro, G
    Garvin, J
    George, D
    Bradley, MB
    Wolownik, K
    Wischhover, C
    Levy, J
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) : 246 - 258
  • [25] Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation
    Al-Kadhimi, Zaid
    Gul, Zartash
    Rodriguez, Roberto
    Chen, Wei
    Smith, Daryn
    Mitchell, Alice
    Abidi, Muneer
    Ayash, Lois
    Deol, Abhinav
    Lum, Lawrence
    Forman, Stephen
    Ratanatharathorn, Voravit
    Uberti, Joseph
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (11) : 1734 - 1744
  • [26] Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation
    Rosenbeck, Lindsay L.
    Kiel, Patrick J.
    Kalsekar, Iftekhar
    Vargo, Craig
    Baute, John
    Sullivan, Cheryl K.
    Wood, Lisa
    Abdelqader, Sahar
    Schwartz, Jennifer
    Srivastava, Shivani
    Abonour, Rafat
    Robertson, Michael J.
    Nelson, Robert P., Jr.
    Cornetta, Kenneth
    Fausel, Christopher A.
    Farag, Sherif S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (06) : 916 - 922
  • [27] Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease
    Krishna, Gopal
    Martinho, Monika
    Chandrasekar, Pranatharthi
    Ullmann, Andrew J.
    Patino, Hernando
    PHARMACOTHERAPY, 2007, 27 (12): : 1627 - 1636
  • [28] A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host Disease
    Lahijani, Sheila
    Rueda-Lara, Maria
    McAndrew, Natalie
    Nelson, Ashley M.
    Guo, Michelle
    Knight, Jennifer M.
    Wiener, Lori
    Miran, Damien M.
    Gray, Tamryn F.
    Keane, Emma P.
    Yek, Ming Hwei
    Sannes, Timothy S.
    Applebaum, Allison J.
    Fank, Patricia
    Babu, Pallavi
    Pozo-Kaderman, Cristina
    Amonoo, Hermioni L.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : S493 - S512
  • [29] Ocular screening for chronic graft-versus-host disease in patients with allogeneic hematopoietic stem cell transplant
    Pearson, Bryan G.
    Cortez, Ray S.
    Khimani, Karima S.
    Gupta, Praveena K.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2025, 60 (01):
  • [30] Risk factors for thrombotic microangiopathy in allogeneic haematopoietic stem cell recipients receiving graft-versus-host disease prophylaxis with tacrolimus plus methotrexate or sirolimus
    Labrador, J.
    Lopez-Corral, L.
    Lopez-Godino, O.
    Vazquez, L.
    Cabrero-Calvo, M.
    Perez-Lopez, R.
    Perez-Lopez, E.
    Guerrero, C.
    Alberca, I.
    Perez-Simon, J. A.
    Miguel, J. F. San
    Gonzalez-Porras, J. R.
    Caballero, M. D.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S58 - S58
12345